Bausch Health Companies Inc. BHC Cash Flow

Bausch health companies inc. (BHC)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'09	Jun'09
Cash Flows From Operating Activities
Cash Flows From Operating Activities
Net loss
-1,887	-1,783	-608	-911	-1,613	-4,144	-3,290	-1,639	-804	2,404	1,380	-1,139	-1,406	-2,408	-2,282	-1,011	-759	-288	600	825	998	880	503	-745	-856	-863	-1,077	-98	-130	-116	28	62	140	159	0	0	0	0	0
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization of intangible assets
2,024	2,075	2,129	2,312	2,565	2,819	3,092	3,087	2,970	2,858	2,746	2,756	2,809	2,866	2,857	2,876	2,791	2,467	2,134	1,847	1,619	1,614	1,658	2,165	2,075	2,015	1,918	1,208	1,112	986	881	800	701	612	0	0	0	0	0
Amortization and write-off of debt premiums, discounts and issuance costs
61	63	66	67	73	79	113	129	131	151	129	127	140	118	110	98	155	145	135	149	68	70	77	70	92	89	92	73	40	36	21	25	28	27	0	0	0	0	0
Asset Impairment Charges
86	75	183	239	527	568	519	836	620	714	657	399	544	422	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Goodwill, Impairment Loss
-	-	-	-	-	2,322	2,213	2,525	2,525	312	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of discounts on long-term debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Amortization of deferred financing costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
In-process research and development impairments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	0	0	-	-	0	0	-	-	0	0	-	109	0	0	0	0	0
Acquisition accounting adjustment on inventory sold
-	-	-	-	-	-	-	-	-	-	-	-	-	38	74	99	138	134	102	88	46	27	175	312	334	372	248	105	88	78	60	56	62	59	0	0	0	-	-
Acquisition-related contingent consideration
46	12	16	-6	-32	-9	-15	-234	-277	-289	-328	-81	-25	-13	-27	-32	-28	-23	-6	-6	-15	-14	19	-19	-18	-29	-61	-21	-17	-5	3	4	-1	-10	0	0	0	-	-
Allowances for losses on trade receivable and inventories
77	75	67	63	65	69	96	104	112	119	149	170	170	174	164	140	130	115	79	72	73	81	79	83	78	68	45	36	26	21	14	9	9	5	0	0	0	-	-
Deferred income taxes
-184	-230	-375	-243	-108	-144	-1,403	-3,221	-3,584	-4,386	-2,911	-1,278	-1,164	-236	-394	-340	-252	-160	-134	31	60	4	-166	-426	-468	-515	-477	-399	-342	-319	-273	-205	-218	-222	0	0	0	0	0
Gain (Loss) on Disposition of Assets
0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
(Gain) loss on disposal of assets and businesses
-	-	-	-	-	-	-	-	-	579	692	364	327	8	5	0	0	-	0	-	-	-	0	-	-	-	0	-	-	-10	-10	-10	-9	5	0	0	0	-	-
Gain (Loss) Related to Litigation Settlement
-1,422	-1,401	-15	34	36	27	-84	-127	-161	-226	-203	-201	-133	-59	26	2	-37	-37	-35	-8	-5	45	-17	-167	-167	-220	-155	-5	-58	-56	-66	-66	-14	-11	0	0	0	-	-
Payments of accrued legal settlements
17	15	6	5	55	224	222	228	391	221	222	231	66	69	68	78	33	33	34	8	6	3	1	12	0	-	0	0	-	41	49	11	10	26	0	0	0	0	-
Loss on deconsolidation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-18	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Share-based compensation
105	102	99	95	90	87	82	79	80	87	101	119	129	165	162	176	169	140	128	98	88	78	73	69	61	45	45	48	56	66	73	72	83	94	0	0	0	0	0
Tax expense (benefit) from share-based compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Excess tax expense (benefits) from share-based compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	-
Foreign exchange loss
-23	-7	-5	6	-6	19	39	51	100	106	54	40	15	-14	16	-13	-17	-95	-169	-193	-198	-135	-68	-8	-24	-9	-1	-7	0	23	26	22	27	4	0	0	0	-	-
Interest expense on cross-currency swaps
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on sale of marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	23	0	0	-	-	0	-	-	-
Gain (Loss) on Extinguishment of Debt
-59	-42	-84	-84	-99	-119	-132	-133	-85	-122	-65	-64	-64	0	0	0	0	-20	-56	-56	-56	-130	-129	-137	-137	-65	-47	-41	-41	-20	0	0	0	-	-	-	0	-	-
Payments of contingent consideration adjustments, including accretion
-	-	-	-	-	-	-	-	-	-	-	-	-	28	0	0	0	-	-0	-7	-9	-11	14	16	11	11	6	4	0	-	0	0	-	-	-	-	-	-	-
Payment of accreted interest on repurchase of convertible debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-
Gain on disposal of investments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Other
-20	-36	-29	-1	5	17	17	22	23	22	-14	-33	-25	-26	35	32	26	33	-6	-16	-15	-32	-28	-13	-9	3	14	17	9	13	41	42	30	18	0	0	0	0	0
Changes in operating assets and liabilities:
Trade receivables
-19	-39	-270	-144	-101	-216	-135	-93	-189	-417	-335	-461	-392	34	1	360	553	626	1,022	797	608	572	399	223	219	300	92	330	272	175	259	120	96	164	0	0	0	0	0
Inventories
235	209	202	114	73	5	2	5	-45	-7	-3	19	116	164	257	281	271	276	255	251	214	193	140	145	167	122	124	87	70	80	72	68	59	11	0	0	0	0	0
Prepaid expenses and other current assets
2	-1	3	-5	17	72	52	63	39	-33	-146	-90	-77	-232	-279	-234	-111	91	396	302	159	110	-75	-118	-103	-121	-100	-46	-37	-11	10	11	0	3	0	0	0	0	0
Accounts payable, accrued and other liabilities
-230	-149	-261	-203	-214	-121	195	254	280	387	125	-23	78	-144	-4	282	332	325	658	467	231	318	-60	-205	-33	-76	-50	87	16	-8	81	-27	0	-	0	0	-	-	-
Accounts payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Accrued liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Income taxes payable, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0
Deferred revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Net cash provided by operating activities
1,349	1,501	1,586	1,593	1,476	1,501	1,760	1,728	1,774	2,290	2,224	2,304	2,484	2,087	2,193	2,360	2,322	2,257	2,471	2,353	2,318	2,312	1,758	1,341	1,271	1,042	830	795	744	656	778	785	721	640	0	0	0	0	0
Cash Flows From Investing Activities
Acquisition of businesses, net of cash acquired
0	180	180	180	180	-5	-5	-5	-5	0	0	0	0	19	1,475	1,591	14,682	15,458	14,122	14,613	1,590	1,102	1,044	4,876	5,322	5,253	7,703	3,509	3,450	3,485	2,466	2,630	2,273	2,464	0	0	0	-	0
Acquisition of intangible assets and other assets
-	-	-	-	-	78	95	99	48	165	154	187	180	56	57	20	26	68	131	205	206	179	137	67	90	69	102	104	72	73	13	19	26	327	0	0	0	0	0
Purchases of property, plant and equipment
295	270	254	203	171	157	148	159	166	171	172	182	211	235	252	250	231	235	244	233	299	292	274	260	159	115	77	109	110	107	96	49	48	58	0	0	0	0	0
Settlement of foreign currency forward exchange contracts
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchases of marketable securities
16	16	10	8	9	7	0	0	0	-	-	-	-	-	-	-	-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from sale of marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	67	103	70	70	53	18	18	26	35	632	632	625	624	9	9	92	86	0	0	0	0	0
Purchase of equity method investment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	0	0	-	-	0	0	-	0	7	18	48	81	0	0	0	-	-
Proceeds from sale of marketable securities
11	10	5	4	6	7	5	5	4	2	2	3	11	17	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest settlements from cross-currency swaps
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from sale of assets and businesses, net of costs to sell
41	45	46	73	67	34	222	1,103	1,928	3,253	3,131	2,232	1,516	199	141	124	13	13	1,479	0	0	-	0	-	-	41	42	53	34	92	112	0	0	-	-	0	-	0	-
Reduction of cash due to deconsolidation
-	-	-	-	-	-	-	-	-	-	-	-	-	30	30	30	30	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net settlement of assumed derivative contracts
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	31	5	5	10,349	0	0	0	0	-	-	-	-	-	0	0	-	-	-	-	-	-	-
Proceeds from sale and leaseback of assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Additions to marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Other
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Net cash used in investing activities
-256	-419	-396	-318	-351	-196	-44	820	1,691	2,887	2,803	1,865	1,135	-125	-1,666	-1,753	-4,448	-15,577	-14,247	-13,335	-10,956	-100	-38	-5,264	-5,529	-5,380	-7,209	-3,037	-2,982	-2,965	-2,505	-2,651	-2,201	-2,808	0	0	0	0	0
Cash Flows From Financing Activities
Cash Flows From Financing Activities
Issuance of long-term debt, net of discounts
4,443	5,960	4,711	4,713	8,977	8,944	10,664	10,666	4,671	9,424	6,231	6,232	6,234	1,220	2,114	2,114	7,036	17,817	17,587	18,142	13,270	1,630	1,845	8,455	8,746	8,385	12,102	5,059	5,360	6,005	3,867	4,435	3,894	5,388	0	0	0	-	-
Repayments of Long-term Debt
4,244	4,406	5,857	5,768	9,991	10,101	13,154	14,200	8,315	14,203	9,768	9,002	9,629	2,436	2,584	1,969	1,370	2,055	3,091	4,692	4,564	3,888	3,124	6,275	6,330	6,326	6,853	2,103	2,056	1,929	1,479	1,459	1,332	2,004	0	0	0	-	-
Borrowings of short-term debt
-	-	-	-	-	-	-	-	-	-	-	-	-	3	4	4	5	8	0	0	0	-	-	-	-	27	30	34	32	35	0	0	0	-	-	-	-	-	-
Repayments of short-term debt
-	-	-	-	-	3	1	2	8	8	8	8	3	3	-3,114	-3,115	6	8	3,125	3,125	0	-	0	0	-	75	42	38	0	-	0	0	-	-	-	-	-	-	-
Repayments of convertible notes assumed
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	75	278	478	613	0	0	0	-	-
Cash dividends paid
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Issuance of common stock, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,433	1,433	1,433	1,433	0	-1	2,269	0	-	0	0	-	-	0	0	-	-	-	-	-	-	-
Repurchases of common shares
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	0	0	-	55	55	55	206	280	345	420	473	639	0	0	0	-	-
Settlement of stock options
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-
Proceeds from exercise of stock options
-	-	-	-	-	-	-	-	-	-	-	-	-	33	33	8	16	30	35	32	28	17	13	12	10	10	17	20	20	23	19	19	23	41	0	0	0	0	0
Tax (expense) benefit from share-based compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	0	-	-7	9	20	24	55	25	16	12	-1	-1	3	26	0	0	0	-	-
Cash settlement of convertible debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-
Cash settlement of call options
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-
Payments of employee withholding taxes related to share-based awards
30	40	40	41	39	10	10	9	9	4	6	7	3	11	11	33	80	88	91	69	32	44	68	80	86	65	45	38	34	31	23	18	24	59	0	0	0	-	-
Payments of acquisition-related contingent consideration
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments of acquisition-related contingent consideration
-	-	-	-	-	-	0	0	48	-	63	104	105	123	115	114	164	151	138	104	108	106	128	129	118	130	122	125	97	103	0	0	0	-	-	-	-	-	-
Payments of deferred consideration
-	-	-	-	-	-	-	-	-	-	-	-	-	540	572	571	555	55	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisition of noncontrolling interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments of financing costs
45	28	66	69	83	102	133	130	92	110	40	71	135	97	100	69	79	103	130	140	65	52	11	48	48	72	88	64	65	33	34	23	26	40	0	0	0	-	0
Other
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	0	-	-	-	0	-	-	-	-
Issuance of 5.375% Convertible Notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Advances under credit facilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Repayments under credit facilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-
Other
-9	-8	-22	-24	-24	-26	-5	-7	-9	-18	-19	-12	-20	-9	0	0	0	-	0	0	0	-	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	0
Net cash used in financing activities
72	1,443	-1,314	-1,226	-1,215	-1,353	-2,693	-3,737	-3,809	-4,963	-3,696	-2,963	-3,665	-1,963	-1,287	-698	1,577	13,624	12,424	11,450	9,969	-2,460	-1,492	1,908	4,420	4,027	6,720	4,394	2,330	3,057	1,731	2,038	1,415	1,948	0	0	0	0	0
Effect of exchange rate changes on cash and cash equivalents
-26	-4	-22	-7	-35	-26	-19	2	43	41	-21	-33	-54	-54	-2	-14	-6	-30	-36	-41	-42	-29	-15	5	0	-5	-2	-7	-10	3	-0	-16	-6	-10	0	0	0	0	0
Net (decrease) increase in cash and cash equivalents and restricted cash
1,139	2,521	-146	42	-125	-74	-996	-1,187	-301	255	1,310	1,173	-100	-55	-761	-106	-554	274	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Net (decrease) increase in cash and cash equivalents
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-2,008	162	-315	338	2,144	83	752	3	156	-71	-230	0	0	0	-	-
Non-Cash Investing and Financing Activities
Acquisition of businesses, contingent and deferred consideration obligations at fair value (Restated)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	73	57	38	76	105	122	222	145	948	876	398	443	0	0	0	-	-
Settlement of convertible debt, equity issued
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-
Acquisition of businesses, debt assumed
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	8	4,226	4,231	4,264	4,264	88	0	-	0	0	-	-	-	-	-	-	-
Additions to marketable securities, accrued but unpaid
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-
Out-license of intangible asset
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-